Cytogenetic aspects of the Canadian early and mid-trimester amniotic fluid trial (CEMAT). Cytogenetic results from a large multicentre randomized controlled study of 2108 amniotic fluids obtained at 11+0-12+6 weeks (EA) and 1999 fluids at 15+0-16+6 weeks (MA) were compared. There was no statistically significant difference in the rate of chromosome abnormalities (EA =1.9 per cent MA=1.7 per cent) or level III mosaicism (EA=0.2 per cent